Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Bowing out of a crowded race, Merck sells a migraine drug to Allergan for $250M
Bowing out of a crowded race, Merck sells a migraine drug to Allergan for $250M
Bowing out of a crowded race, Merck sells a migraine drug to Allergan for $250M
Submitted by
admin
on July 7, 2015 - 9:10am
Source:
Fierce Biotech
News Tags:
Merck
migraines
Allergan
M&A
MK-1602
MK-8031
Headline:
Bowing out of a crowded race, Merck sells a migraine drug to Allergan for $250M
Do Not Allow Advertisers to Use My Personal information
